UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
21.85
+0.77 (3.65%)
At close: Jan 27, 2026, 4:00 PM EST
22.08
+0.23 (1.05%)
After-hours: Jan 27, 2026, 7:51 PM EST
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.02 billion as of January 27, 2026. Its market cap has increased by 119.53% in one year.
Market Cap
1.02B
Enterprise Value
1.03B
1-Year Change
119.53%
Ranking
Category
Stock Price
$21.85
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.02B, an increase of 462.27%. That is a compound annual growth rate of 21.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 986.70M | -10.00% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.01B |
| Ventyx Biosciences | 1.00B |
| BridgeBio Oncology Therapeutics | 1.00B |
| Vir Biotechnology | 990.57M |
| Annexon | 961.41M |
| ArriVent BioPharma | 939.15M |
| Maravai LifeSciences Holdings | 938.44M |
| Xencor | 916.91M |